Outsourcing

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

As the development pipeline becomes more saturated with complex molecules and patient experience becomes more important, developers are looking to outsourcing partners to provide more specialized expertise and solutions.

The Demands of the Perfect Dose

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Establishing OEL data and ensuring appropriate engineering controls are crucial aspects of safe handling.

Best Practices in Handling HPAPIs

Lina Cogan is senior director of global sourcing and procurement for LGM Pharma.

Hamilton J. Lenox is senior vice-president, business development for LGM Pharma.

Selwyn Lustman is senior vice-president global sourcing and procurement for LGM Pharma.

Sourcing hard-to-find ingredients and establishing a reliable supply chain can stretch the resources of a small- to mid-size pharma company. 

Planning a Successful API Procurement Strategy

Jonathan Loughrey is head of screening, Cambrex Edinburgh.

An understanding-during early development-of the solid form landscape of an API can enhance product quality and manufacturing processes.

Uncovering Hidden Risks in Solid-State API Properties

Bora Pharmaceuticals has announced it has achieved success in the latest FDA general inspection of its Zhunan facility with zero 483 observations.

Taiwanese CDMO Gains FDA Approval for Zhunan Facility

The new antibody, Citryll’s CIT-013, could offer new treatment options for various human diseases including lupus, vasculitis, pulmonary fibrosis, and organ damage due to sepsis.

Lonza, Citryll Partner to Manufacture New NET Antibody

The partnership will provide cost effective biologics for the world market.

Celltrion and Lonza Sign Contract to Manufacture Remsima Drug Substance

The joint venture, named BacThera, will operate out of headquarters in Basel, Switzerland and will serve pre-clinical to Phase II projects, with the ability to expand to Phase III and commercial manufacturing in the future.

Chr. Hansen, Lonza Joint Venture Gets Anti-Trust Nod to Manufacture Live Biotherapeutics

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

CDMOs are adding facilities and services to their portfolios in anticipation of the biologics industry’s continued growth.

Biologics Continue to Grow and Create Outsourcing Opportunities

Alvotech and Prestige Biopharma, have announced the formation of a new contract manufacturing partnership for the commercial production of a biosimilar.

Contract Manufacturing Services